Rockwell Medical Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | +196.5% | -79.8% | -503.1% | – | -170.9% | – | -107.3% | – | – | |
| – | -2.5% | -0.9% | +0.7% | -1.1% | +0.0% | -0.7% | +4.5% | -3.4% | +0.4% | -6.4% | -3.7% | – | |
| – | +2.8% | +15.1% | +34.7% | -5.0% | +19.0% | +16.5% | -14.2% | +39.3% | -14.1% | +4.8% | -15.9% | – | |
| – | – | – | – | – | -99.4% | -74,860.0% | – | -161.3% | – | -114.7% | – | – | |
| – | +168.8% | +223.3% | +105.8% | -33.2% | +106.8% | -84.1% | +160.3% | +39.6% | -62.4% | +394.2% | +45.2% | – | |
| – | – | -106.9% | – | -456.0% | -94.6% | -99.7% | +10,200.0% | +4,083.5% | -4.1% | -97.0% | +299.2% | – | |
| – | – | – | – | – | +0.6% | +1.2% | -38.0% | +49.8% | -4.0% | +1.3% | -41.5% | – | |
| – | -105.8% | – | +1,060.1% | +12.0% | +20.7% | -128.0% | -17.0% | – | -115.7% | -23.2% | -16.0% | – | |
| – | – | -291.3% | – | -90.9% | +599.8% | -228.5% | – | +3.4% | -357.0% | – | – | – | |
| – | – | – | – | +253.3% | -88.5% | -855.3% | – | -191.4% | – | -126.8% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.